{
  "alleleExist":false,
  "dataVersion":"v4.5",
  "diagnosticImplications":[
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Dx3",
      "pmids":[
        "24296945",
        "22891276",
        "25779943",
        "22891273"
      ],
      "tumorType":{
        "children":{},
        "code":"SMZL",
        "color":"LimeGreen",
        "id":578,
        "level":6,
        "mainType":{
          "id":null,
          "name":"Mature B-Cell Neoplasms",
          "tumorForm":"LIQUID"
        },
        "name":"Splenic Marginal Zone Lymphoma",
        "parent":"MZL",
        "tissue":"Lymphoid",
        "tumorForm":"LIQUID"
      }
    }
  ],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"NOTCH2 encodes a transmembrane receptor that regulates many aspects of development by affecting cell-fate determination.",
  "highestDiagnosticImplicationLevel":"LEVEL_Dx3",
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":false,
  "lastUpdate":"01/09/2023",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[
        "15994325",
        "22006338",
        "16773578"
      ]
    },
    "description":"The NOTCH2 1_2009trunc mutations are located in exons 1 through 33 of the gene. These mutations have been identified in Alagille syndrome and squamous cell carcinoma (PMID: 16773578, 22006338). In vivo studies with Drosophila expressing NOTCH2 W330* demonstrate that NOTCH2 1_2009trunc mutations are likely inactivating as measured by the loss of EGF repeats 11-13 to allow for ligand interaction (PMID: 15994325).",
    "knownEffect":"Likely Loss-of-function"
  },
  "oncogenic":"Likely Oncogenic",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"M1?",
    "alterationType":null,
    "consequence":null,
    "entrezGeneId":4853,
    "hgvs":null,
    "hugoSymbol":"NOTCH2",
    "id":null,
    "proteinEnd":null,
    "proteinStart":null,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":false,
  "variantSummary":"The NOTCH2 M1? mutation is likely oncogenic.",
  "vus":false
}